Acarix AB publishes Interim Report, April - June 2024 - Morningstar
| ACARIX Stock | SEK 0.32 0.01 3.03% |
About 62% of Acarix AS's investor base is looking to short. The analysis of current outlook of investing in Acarix AS suggests that many traders are alarmed regarding Acarix AS's prospects. The current market sentiment, together with Acarix AS's historical and current headlines, can help investors time the market. In addition, many technical investors use Acarix AS stock news signals to limit their universe of possible portfolio assets.
Acarix |
Acarix AB publishes Interim Report, April - June 2024 Morningstar
Read at news.google.com
 |
Acarix AS Fundamental Analysis
We analyze Acarix AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acarix AS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acarix AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Acarix AS is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Acarix AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acarix AS stock to make a market-neutral strategy. Peer analysis of Acarix AS could also be used in its relative valuation, which is a method of valuing Acarix AS by comparing valuation metrics with similar companies.
Peers
Acarix AS Related Equities
| BIOVIC-B | Biovica International | 3.89 | ||||
| SANION | Saniona AB | 3.56 | ||||
| CANTA | Cantargia | 2.69 | ||||
| EXPRS2 | ExpreS2ion Biotech | 3.32 |
Complementary Tools for Acarix Stock analysis
When running Acarix AS's price analysis, check to measure Acarix AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acarix AS is operating at the current time. Most of Acarix AS's value examination focuses on studying past and present price action to predict the probability of Acarix AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acarix AS's price. Additionally, you may evaluate how the addition of Acarix AS to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |